FDx Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,518
Closed -$548K 669
2019
Q3
$548K Buy
5,518
+1,143
+26% +$109K 0.04% 328
2019
Q2
$404K Buy
4,375
+54
+1% +$5.13K 0.02% 536
2019
Q1
$408K Sell
4,321
-5,070
-54% -$443K 0.02% 500
2018
Q4
$602K Buy
9,391
+2,363
+34% +$174K 0.05% 267
2018
Q3
$629K Sell
7,028
-546
-7% -$48.3K 0.02% 464
2018
Q2
$602K Sell
7,574
-99
-1% -$8.22K 0.02% 493
2018
Q1
$685K Sell
7,673
-16,026
-68% -$1.54M 0.02% 629
2017
Q4
$2.47M Sell
23,699
-3,379
-12% -$381K 0.07% 253
2017
Q3
$3.95M Buy
27,078
+1,617
+6% +$220K 0.11% 152
2017
Q2
$3.31M Sell
25,461
-6,067
-19% -$743K 0.1% 170
2017
Q1
$3.92M Buy
31,528
+1,529
+5% +$183K 0.12% 158
2016
Q4
$3.47M Buy
29,999
+14,750
+97% +$1.64M 0.1% 192
2016
Q3
$1.59M Sell
15,249
-5,743
-27% -$622K 0.07% 261
2016
Q2
$2.07M Buy
20,992
+8,646
+70% +$894K 0.09% 195
2016
Q1
$1.24M Buy
12,346
+725
+6% +$74.7K 0.06% 303
2015
Q4
$1.39M Buy
11,621
+2,556
+28% +$296K 0.06% 270
2015
Q3
$981K Sell
9,065
-951
-9% -$118K 0.08% 254
2015
Q2
$1.16M Sell
10,016
-6,484
-39% -$741K 0.06% 294
2015
Q1
$1.9M Buy
16,500
+2,035
+14% +$243K 0.04% 350
2014
Q4
$1.62M Buy
14,465
+7,011
+94% +$739K 0.1% 195
2014
Q3
$706K Buy
7,454
+4,208
+130% +$380K 0.05% 450
2014
Q2
$279K Buy
+3,246
New +$247K 0.02% 811

Other funds holding CELG

FDx Advisors's CELG Position: Q4 2019 in Review

FDx Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,518 shares — an estimated $548K sold.

FDx Advisors first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $3.95M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • FDx Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • FDx Advisors sold 5,518 Celgene Corp shares in Q4 2019, an estimated $548K.
  • FDx Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • FDx Advisors's Celgene Corp position peaked at $3.95M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on FDx Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.